This inventor holds 1 USPTO granted patent. Top assignee: Stallergenes. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Karine Jain: Innovator in Immunotherapy
Introduction
Karine Jain is a prominent inventor based in Versailles, France. She has made significant contributions to the field of immunotherapy, particularly in the development of biomarkers that can predict the efficacy of treatment. Her work is vital for improving patient outcomes in immunotherapy.
Latest Patents
Karine Jain holds a patent titled "Biomarkers of immunotherapy efficacy." This invention relates to proteins that serve as markers for the effectiveness of sublingual immunotherapy. The proteins developed by Jain can predict how responsive a patient will be to immunotherapy, which is crucial for selecting suitable candidates for this type of treatment. She has 1 patent to her name.
Career Highlights
Karine Jain is currently employed at Stallergenes, a company known for its focus on allergy immunotherapy. Her role at Stallergenes allows her to apply her innovative ideas in a practical setting, contributing to advancements in the field.
Collaborations
Throughout her career, Karine has collaborated with notable colleagues, including Julien Bouley and Philippe Moingeon. These collaborations have further enriched her research and development efforts in immunotherapy.
Conclusion
Karine Jain is a trailblazer in the field of immunotherapy, with her innovative work on biomarkers significantly impacting patient care. Her contributions continue to pave the way for advancements in this critical area of medicine.